- BBS Pharmacy, Inc. dba B&B Pharmacy
- Issuing Office:
Division of Pharmaceutical Quality Operations IV
VIA UNITED PARCEL SERVICE
August 31, 2017
Julie H. Yoon, Pharm.D., Owner
BBS Pharmacy, Inc. dba B&B Pharmacy
10244 Rosecrans Avenue
Bellflower, CA 90706-2602
Dear Dr. Yoon:
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter [WL # 45-16] dated September 2, 2016. We acknowledge that your firm no longer produces sterile drug products. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
CDR Steven E. Porter, Jr.
Director, Division of Pharmaceutical Quality Operations IV
Virginia Herold, Executive Officer
California State Board of Pharmacy
1625 N Market Blvd N219
Sacramento, CA 95834